Literature DB >> 32152584

Improving prevention strategies for cardiometabolic disease.

Naveed Sattar1, Jason M R Gill2, William Alazawi3.   

Abstract

There is a growing burden of cardiometabolic disease in many parts of the world. Despite some progress in its prevention, more can be done to tackle risks of its development in the community and in different specialty clinics. Currently, the identification and management of those at elevated risk of developing cardiovascular disease or diabetes or with conditions such as fatty liver disease remains fragmented and is not linked to constructive lifestyle advice. In this Perspective, we argue for a more consistent weight-management approach, alongside a holistic assessment of the risk for developing cardiometabolic diseases, offering patients a range of simple or more-intensive evidence-based lifestyle options in an empathetic manner, with encouragement for repeated attempts and a willingness to embrace failure.

Entities:  

Mesh:

Year:  2020        PMID: 32152584     DOI: 10.1038/s41591-020-0786-7

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  36 in total

Review 1.  The Impact of Comorbidities on the Pharmacological Management of Type 2 Diabetes Mellitus.

Authors:  Shazia Hussain; Tahseen A Chowdhury
Journal:  Drugs       Date:  2019-02       Impact factor: 9.546

Review 2.  The changing face of diabetes complications.

Authors:  Edward W Gregg; Naveed Sattar; Mohammed K Ali
Journal:  Lancet Diabetes Endocrinol       Date:  2016-05-04       Impact factor: 32.069

3.  SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.

Authors:  Thomas A Zelniker; Stephen D Wiviott; Itamar Raz; Kyungah Im; Erica L Goodrich; Marc P Bonaca; Ofri Mosenzon; Eri T Kato; Avivit Cahn; Remo H M Furtado; Deepak L Bhatt; Lawrence A Leiter; Darren K McGuire; John P H Wilding; Marc S Sabatine
Journal:  Lancet       Date:  2018-11-10       Impact factor: 79.321

4.  2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).

Authors:  Massimo F Piepoli; Arno W Hoes; Stefan Agewall; Christian Albus; Carlos Brotons; Alberico L Catapano; Marie-Therese Cooney; Ugo Corrà; Bernard Cosyns; Christi Deaton; Ian Graham; Michael Stephen Hall; F D Richard Hobbs; Maja-Lisa Løchen; Herbert Löllgen; Pedro Marques-Vidal; Joep Perk; Eva Prescott; Josep Redon; Dimitrios J Richter; Naveed Sattar; Yvo Smulders; Monica Tiberi; H Bart van der Worp; Ineke van Dis; W M Monique Verschuren; Simone Binno
Journal:  Eur Heart J       Date:  2016-05-23       Impact factor: 29.983

Review 5.  Obesity: global epidemiology and pathogenesis.

Authors:  Matthias Blüher
Journal:  Nat Rev Endocrinol       Date:  2019-05       Impact factor: 43.330

Review 6.  National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants.

Authors:  Goodarz Danaei; Mariel M Finucane; Yuan Lu; Gitanjali M Singh; Melanie J Cowan; Christopher J Paciorek; John K Lin; Farshad Farzadfar; Young-Ho Khang; Gretchen A Stevens; Mayuree Rao; Mohammed K Ali; Leanne M Riley; Carolyn A Robinson; Majid Ezzati
Journal:  Lancet       Date:  2011-06-24       Impact factor: 79.321

7.  Short-term progression of cardiometabolic risk factors in relation to age at type 2 diabetes diagnosis: a longitudinal observational study of 100,606 individuals from the Swedish National Diabetes Register.

Authors:  Andri O Steinarsson; Araz Rawshani; Soffia Gudbjörnsdottir; Stefan Franzén; Ann-Marie Svensson; Naveed Sattar
Journal:  Diabetologia       Date:  2018-01-09       Impact factor: 10.122

8.  Rates of glycaemic deterioration in a real-world population with type 2 diabetes.

Authors:  Louise A Donnelly; Kaixin Zhou; Alex S F Doney; Chris Jennison; Paul W Franks; Ewan R Pearson
Journal:  Diabetologia       Date:  2017-12-19       Impact factor: 10.122

9.  Body mass index and body composition in relation to 14 cardiovascular conditions in UK Biobank: a Mendelian randomization study.

Authors:  Susanna C Larsson; Magnus Bäck; Jessica M B Rees; Amy M Mason; Stephen Burgess
Journal:  Eur Heart J       Date:  2020-01-07       Impact factor: 35.855

10.  Trends in cardiovascular risk factors among U.S. men and women with and without diabetes, 1988-2014.

Authors:  Xingxing Sun; Tingting Du
Journal:  BMC Public Health       Date:  2017-11-22       Impact factor: 3.295

View more
  20 in total

1.  MG53 E3 Ligase-Dead Mutant Protects Diabetic Hearts From Acute Ischemic/Reperfusion Injury and Ameliorates Diet-Induced Cardiometabolic Damage.

Authors:  Han Feng; Hao Shen; Matthew J Robeson; Yue-Han Wu; Hong-Kun Wu; Geng-Jia Chen; Shuo Zhang; Peng Xie; Li Jin; Yanyun He; Yingfan Wang; Fengxiang Lv; Xinli Hu; Yan Zhang; Rui-Ping Xiao
Journal:  Diabetes       Date:  2022-02-01       Impact factor: 9.461

2.  Dual-modality Imaging of Angiogenesis in Unstable Atherosclerotic Plaques with VEGFR2-Targeted Upconversion Nanoprobes in vivo.

Authors:  Yan Fang; Ruichen Yang; Yi Hou; Yabin Wang; Ning Yang; Mengqi Xu; Sulei Li; Shan Gao; Min Jiang; Jingyang Fan; Yazhuo Hu; Zhenzhen Xu; Lei Gao; Feng Cao
Journal:  Mol Imaging Biol       Date:  2022-05-23       Impact factor: 3.484

3.  Association of Healthy Lifestyle and Life Expectancy in Patients With Cardiometabolic Multimorbidity: A Prospective Cohort Study of UK Biobank.

Authors:  Xunjie Cheng; Feiyun Ouyang; Tianqi Ma; Yi Luo; Jinghua Yin; Jinchen Li; Guogang Zhang; Yongping Bai
Journal:  Front Cardiovasc Med       Date:  2022-06-09

4.  Defining Multimorbidity and Its Impact in Older United States Veterans Newly Treated for Multiple Myeloma.

Authors:  Nathanael R Fillmore; Clark DuMontier; Cenk Yildirim; Jennifer La; Mara M Epstein; David Cheng; Diana Cirstea; Sarvari Yellapragada; Gregory A Abel; J Michael Gaziano; Nhan Do; Mary Brophy; Dae H Kim; Nikhil C Munshi; Jane A Driver
Journal:  J Natl Cancer Inst       Date:  2021-08-02       Impact factor: 13.506

5.  Efficient Automated Disease Diagnosis Using Machine Learning Models.

Authors:  Naresh Kumar; Nripendra Narayan Das; Deepali Gupta; Kamali Gupta; Jatin Bindra
Journal:  J Healthc Eng       Date:  2021-05-04       Impact factor: 2.682

6.  External validation of the European risk assessment tool for chronic cardio-metabolic disorders in a Middle Eastern population.

Authors:  Samaneh Asgari; Fatemeh Moosaie; Davood Khalili; Fereidoun Azizi; Farzad Hadaegh
Journal:  J Transl Med       Date:  2020-07-02       Impact factor: 5.531

7.  Kanglexin delays heart aging by promoting mitophagy.

Authors:  Hui-Min Li; Xin Liu; Zi-Yu Meng; Lei Wang; Li-Min Zhao; Hui Chen; Zhi-Xia Wang; Hao Cui; Xue-Qing Tang; Xiao-Han Li; Wei-Na Han; Xue Bai; Yuan Lin; Heng Liu; Yong Zhang; Bao-Feng Yang
Journal:  Acta Pharmacol Sin       Date:  2021-05-25       Impact factor: 6.150

Review 8.  The impact of gut microbiota metabolites on cellular bioenergetics and cardiometabolic health.

Authors:  Lenka Tomasova; Marian Grman; Karol Ondrias; Marcin Ufnal
Journal:  Nutr Metab (Lond)       Date:  2021-07-15       Impact factor: 4.169

9.  Synergistic effects of exercise and catalase overexpression on gut microbiome.

Authors:  Jeremy R Chen See; Deborah Amos; Justin Wright; Regina Lamendella; Nalini Santanam
Journal:  Environ Microbiol       Date:  2021-08-07       Impact factor: 5.476

Review 10.  Obesity as a Risk Factor for Severe COVID-19: Summary of the Best Evidence and Implications for Health Care.

Authors:  Naveed Sattar; Jonathan Valabhji
Journal:  Curr Obes Rep       Date:  2021-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.